1. Home
  2. SLS vs NCTY Comparison

SLS vs NCTY Comparison

Compare SLS & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • NCTY
  • Stock Information
  • Founded
  • SLS 2012
  • NCTY 1999
  • Country
  • SLS United States
  • NCTY China
  • Employees
  • SLS N/A
  • NCTY N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • NCTY Business Services
  • Sector
  • SLS Health Care
  • NCTY Consumer Discretionary
  • Exchange
  • SLS Nasdaq
  • NCTY Nasdaq
  • Market Cap
  • SLS 169.6M
  • NCTY 156.7M
  • IPO Year
  • SLS N/A
  • NCTY 2004
  • Fundamental
  • Price
  • SLS $1.71
  • NCTY $9.36
  • Analyst Decision
  • SLS
  • NCTY
  • Analyst Count
  • SLS 0
  • NCTY 0
  • Target Price
  • SLS N/A
  • NCTY N/A
  • AVG Volume (30 Days)
  • SLS 3.0M
  • NCTY 89.6K
  • Earning Date
  • SLS 05-13-2025
  • NCTY 01-01-0001
  • Dividend Yield
  • SLS N/A
  • NCTY N/A
  • EPS Growth
  • SLS N/A
  • NCTY N/A
  • EPS
  • SLS N/A
  • NCTY N/A
  • Revenue
  • SLS N/A
  • NCTY $15,305,175.00
  • Revenue This Year
  • SLS N/A
  • NCTY N/A
  • Revenue Next Year
  • SLS N/A
  • NCTY N/A
  • P/E Ratio
  • SLS N/A
  • NCTY N/A
  • Revenue Growth
  • SLS N/A
  • NCTY N/A
  • 52 Week Low
  • SLS $0.77
  • NCTY $5.75
  • 52 Week High
  • SLS $2.12
  • NCTY $20.59
  • Technical
  • Relative Strength Index (RSI)
  • SLS 54.26
  • NCTY 32.45
  • Support Level
  • SLS $1.36
  • NCTY $11.21
  • Resistance Level
  • SLS $2.12
  • NCTY $11.95
  • Average True Range (ATR)
  • SLS 0.18
  • NCTY 0.75
  • MACD
  • SLS -0.01
  • NCTY -0.21
  • Stochastic Oscillator
  • SLS 46.05
  • NCTY 8.21

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About NCTY The9 Limited American Depository Shares

The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.

Share on Social Networks: